Form 4 Tracker
Christopher Gibson

Director · 14 filings · Latest: Jun 5, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Gibson Christopher—Aug 21, 2026
Proposed Sale
$3.3977,290$262.0K—
RXRX
Gibson Christopher—Aug 20, 2026
Proposed Sale
$3.4075,000$255.0K—
RXRX
Gibson Christopher—Aug 19, 2026
Proposed Sale
$3.28100,000$327.5K—
RXRX
Gibson Christopher—Aug 18, 2026
Proposed Sale
$3.0026,806$80.4K—
RXRX
Gibson Christopher—Aug 13, 2026
Proposed Sale
$3.31100,000$331.0K—
RXRX
Gibson Christopher—Aug 12, 2026
Proposed Sale
$3.3750,000$168.5K—
RXRX
Gibson Christopher—Aug 10, 2026
Proposed Sale
$3.27100,000$326.8K—
RXRX
Gibson Christopher—Aug 7, 2026
Proposed Sale
$3.25100,000$325.4K—
RXRX
Gibson Christopher—Aug 4, 2026
Proposed Sale
$3.2775,000$244.9K—
RXRX
Gibson Christopher—Jul 30, 2026
Proposed Sale
$3.0075,000$225.0K—
RXRX
Gibson Christopher—Jul 29, 2026
Proposed Sale
$3.0350,000$151.4K—
RXRX
Gibson Christopher—Jul 27, 2026
Proposed Sale
$3.0550,000$152.7K—
RXRX
Gibson Christopher—Jul 21, 2026
Proposed Sale
$3.04100,000$304.3K—
RXRX
Gibson Christopher—Jul 20, 2026
Proposed Sale
$2.90100,000$289.8K—
RXRX
Gibson Christopher—Jul 17, 2026
Proposed Sale
$2.97100,000$296.7K—
RXRX
Gibson Christopher—Jul 16, 2026
Proposed Sale
$3.11100,000$311.1K—
RXRX
Gibson Christopher—Jul 15, 2026
Proposed Sale
$3.33123,334$410.3K—
RXRX
Gibson Christopher—Jul 14, 2026
Proposed Sale
$3.30100,000$330.5K—
RXRX
Gibson Christopher—Jul 13, 2026
Proposed Sale
$3.43100,000$343.0K—
RXRX
Gibson Christopher—Jul 10, 2026
Proposed Sale
$3.54100,000$353.6K—

Page 1 of 4

Next →